Generer rapport
Copenhagen Contractors A/S
Skagerrakvej 4, 2150 Nordhavn, CVR 29519226
Virksomhedsform
Aktieselskab
Etableret
2006
Størrelse
Store
Ansatte
368
Omsætning
412
MDKK
Bruttofortj.
161
MDKK
Primært resultat (EBIT)
-62.459.266
DKK
Årets resultat
-44.629.811
DKK
Egenkapital
188
MDKK
Reklamebeskyttet virksomhed
Denne virksomhed er reklamebeskyttet. Det betyder bl.a. at oplysningerne ikke må bruges til reklamehenvendelser. annonce
Flere nøgletal og analyser?
Med en Bisbase Premium konto får du flere nøgletal for både virksomheder, koncerner og brancher samt adgang til eksklusive brancher indeholdende virksomheder nøje sammensat af eksperter. Og vil du lave dine egne analyser kan du også det! Det tager få minutter at få adgang - og det behøver ikke at koste dig noget!
Rang Årets resultat
Rang i branche
2.240/2.243
"Bund 10%"
Rang i Danmark
341.048/342.443
"Bund 10%"
Direktion top 3
Jeppe Handwerk 8 | CEO |
Bestyrelse top 3
Bjørn Damgaard Mortensen 8 | Bestyrelsesformand |
Jeppe Handwerk 8 | Bestyrelsesmedlem |
Meta Birgitte Zachau Handwerk 7 | Bestyrelsesmedlem |
Legale ejere top 3
100% | Copenhagen Group A/S | DK |
Tegningsregler
Selskabet tegnes af to bestyrelsesmedlemmer eller af den administrerende direktør alene.
Stamoplysninger baseret på CVR
Navn | Copenhagen Contractors A/S |
Binavne | Copenhagen Consult A/S, Copenhagen Medical A/S, Medicalme A/S Vis mere |
CVR | 29519226 |
Adresse | Skagerrakvej 4, 2150 Nordhavn |
Branche | Anden bygge- og anlægsvirksomhed, som kræver specialisering [439990] |
Etableret | 26-04-2006 (17 år) |
Første regnskabsperiode | 26-04-2006 til 30-06-2007 |
Virksomhedsform | Aktieselskab |
Antal ansatte | 13 (årsværk:8) |
Reklamebeskyttelse | Ja |
Revisor | Christensen Kjærulff Statsautoriseret Revisionsaktieselskab siden 26-04-2006 |
Regnskabsperiode | 01-01 til 31-12 |
Selskabskapital | 2.000.000 DKK 500.000 DKK (26-04-2006 - 08-06-2009) |
Vedtægter seneste | 24-08-2022 |
Medlem af brancherne
- Anden bygge- og anlægsvirksomhed, som kræver specialiseringNACE6 indeholdende 4.922 virk.
- Anden bygge- og anlægsvirksomhed, som kræver specialiseringNACE3 indeholdende 10.153 virk.
- Bygge- og anlægsvirksomhed, som kræver specialiseringNACE2 indeholdende 41.862 virk.
- Bygge- og anlægsvirksomhedNACE1 indeholdende 50.037 virk.
Formål
Selskabets formål er at drive entreprenørvirksomhed samt virksomhed ved levering af diverse serviceydelser til internationale organisationer og dermed beslægtet virksomhed.
Regnskab
2022 | 2021 | 2020 | |
---|---|---|---|
Valuta/enhed | 000' DKK | 000' DKK | 000' DKK |
Omsætning | 411.863 - | - - | - - |
Bruttofortjeneste | 161.391 -90% | 1.657.355 +13.325% | 12.345 +6.758% |
Årets resultat | -44.630 - | 711.745 +10.577% | 6.666 - |
Egenkapital | 187.572 -19% | 232.202 +2.121% | 10.456 +176% |
Balance | 221.766 -67% | 675.271 +787% | 76.156 +1.543% |
Ledelsesberetning
Development in activities and financial matters
In 2021 revenue was primarily generated from COVID-19 antigen (AG) testing services provided by Copenhagen Medical A/S across the Capital Region of Denmark. Throughout 2021, we Copenhagen Medical became a key partner of the Danish Government in providing COVID-19 testing services to the general population, bringing down infection rates and thereby supporting the fight against the COVID-19 pandemic.
These activities continued into Q1 of 2022, after which the contracts ended and the need for mass testing and vaccinations disappeared as society normalized after the epidemic.
In the first half of 2022, the company continued its efforts for 10 strategically located health centres, which should strengthen the company's position in the health field and be a supplement to the public healthcare.
However, the development in this business area has not proceeded as expected, which is why the company has chosen to reduce activity in this segment during the second half of 2022 – which result for the year is also affected by.
The result is also significantly influenced by the fact that the company wanted to ensure the necessary readiness for covid-19 antigen tests, as no one knew when the demand would stop. The excess number of tests - which the company invested in, in order to have the necessary preparedness if the pandemic continued - the company subsequently extraordinarily wrote down by approx. DKK 52 million.
In addition to the sale of medical equipment and services, Copenhagen Contractors A/S continued to provide services under the wash-down and disinfection services framework contract with the Danish Defense throughout 2022.
As a result of the above, total revenue decreased from t.DKK 2.677.000. in 2021 to t.DKK 411.863. in 2022. Income or loss from ordinary and net profit after taxes decreased significantly from t.DKK 711.745 io. in 2021, to t.DKK–43.114 in 2022. In 2022 the company’s cash and cash equivalent’s decreased by t.DKK 91.569 i.e. from t.114.466.to t.DKK 22.897. Under the circumstances, management considers the result for the year to be expected but unsatisfactory.
In 2021 revenue was primarily generated from COVID-19 antigen (AG) testing services provided by Copenhagen Medical A/S across the Capital Region of Denmark. Throughout 2021, we Copenhagen Medical became a key partner of the Danish Government in providing COVID-19 testing services to the general population, bringing down infection rates and thereby supporting the fight against the COVID-19 pandemic.
These activities continued into Q1 of 2022, after which the contracts ended and the need for mass testing and vaccinations disappeared as society normalized after the epidemic.
In the first half of 2022, the company continued its efforts for 10 strategically located health centres, which should strengthen the company's position in the health field and be a supplement to the public healthcare.
However, the development in this business area has not proceeded as expected, which is why the company has chosen to reduce activity in this segment during the second half of 2022 – which result for the year is also affected by.
The result is also significantly influenced by the fact that the company wanted to ensure the necessary readiness for covid-19 antigen tests, as no one knew when the demand would stop. The excess number of tests - which the company invested in, in order to have the necessary preparedness if the pandemic continued - the company subsequently extraordinarily wrote down by approx. DKK 52 million.
In addition to the sale of medical equipment and services, Copenhagen Contractors A/S continued to provide services under the wash-down and disinfection services framework contract with the Danish Defense throughout 2022.
As a result of the above, total revenue decreased from t.DKK 2.677.000. in 2021 to t.DKK 411.863. in 2022. Income or loss from ordinary and net profit after taxes decreased significantly from t.DKK 711.745 io. in 2021, to t.DKK–43.114 in 2022. In 2022 the company’s cash and cash equivalent’s decreased by t.DKK 91.569 i.e. from t.114.466.to t.DKK 22.897. Under the circumstances, management considers the result for the year to be expected but unsatisfactory.
17-07-2023